AVMA news
Shortage of cancer drugs having devastating effects on patients, veterinarians
Chemotherapy drugs, including cisplatin and carboplatin, have been in short supply for months. The situation is affecting animal patients and…
JAVMA news
Zoetis to acquire Abbott assets
Zoetis Inc. announced Nov. 17, 2014, an agreement to purchase Abbott Laboratories’ animal health assets for $255 million.
AVMA news
Drug approved to treat dogs for chemotherapy-related diarrhea
Food and Drug Administration officials granted conditional approval in mid-December for the oral prescription drug Canalevia-CA1, the first drug with…
JAVMA news
Vaccine to treat osteosarcoma in dogs receives conditional license
Aratana Therapeutics Inc. announced Dec. 20, 2017, that the Department of Agriculture’s Center for Veterinary Biologics has granted a conditional…
JAVMA news
Phi Zeta presents 2019 research awards
Phi Zeta, the international honor society of veterinary medicine, announced the winners of the 2019 Research Manuscript Awards at its July annual…
JAVMA news
Specialty board recognizes equine imaging, not botanical medicine
The AVMA American Board of Veterinary Specialties has granted provisional recognition of equine diagnostic imaging as a specialty within the American…
JAVMA news
Progress made in feline sarcoma research
In the early 1990s, veterinarians became aware that some cats developed sarcomas at the infection sites used to administer vaccines.
JAVMA news
GHLIT offers genetic tests for drug response
A new genetic testing program to predict patients' response to particular drugs is now available from the AVMA Group Health and Life Insurance Trust…
JAVMA news
Finding a future for osteosarcoma patients
Ana M. Cilursu, MD, lost three Rottweilers in a row to bone cancer.